News List

SCYNEXIS participates at 2017 BIO International Convention

Marco Taglietti, President & CEO of  SCYNEXIS will participate in a panel on antifungal agents at the 2017 BIO International Conference.

By Team ABLE

SCYNEXIS, a biotechnology company delivering anti-infective therapies for difficult-to-treat and often life-threatening infections, has announced that Marco Taglietti, President and Chief Executive Officer, will participate in a panel at the 2017 BIO International Conference at the San Diego Convention Center on Tuesday, June 20, 2017, at 4:15 p.m. 

The panel, “Antifungus Among Us: Recognizing Vulnerability and Opportunity with the Next-Generation of Antifungals,” will focus on the growing global health epidemic and highlight the urgent needs and opportunities in the antifungal space.